Cdc2-like kinase 1 (CLK1) has been recognized as a potential anti-influenza target owing to alternative splicing of the M1 gene in influenza viruses (Karlas et al., 2010; Li et al., 2018). This evidence concerns the gene CLK1 and influenza.